On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
group sequential design
.
Show all posts
Showing posts with label
group sequential design
.
Show all posts
Friday, March 03, 2023
Risk of Stopping Trial Early for Treatment Benefit - Story of Veru's Sabizabulin for Treatment of Covid
›
Today, we learned that FDA declined to approve the emergency use authorization (EUA) for Veru's sabizabulin for the treatment of Covid. ...
2 comments:
Thursday, December 01, 2022
Sample size re-estimation or sample size increase?
›
Recently, a press release from a biotech company caught my eye. This seems to be an example of the adaptive design with sample size re-esti...
1 comment:
›
Home
View web version
